Search
Please select the unit you wish to search and enter the keyword in the text field below.
You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.{br}{br}TLC provides this link as a service to website visitors. TLC is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.{br}{br}Click “STAY” to return to tlcbio.com or “CONTINUE” to proceed.
TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the company will present at the 42nd Annual JP Morgan Healthcare Conference at 2:00pm PT on Tuesday, January 9, 2024. As a part of the APAC track, TLC will present at the Golden Gate Ballroom at the Marriott Marquis, 780 Mission Street, San Francisco.
Company management will provide updates on the status of the Company’s innovative product candidates. A live webcast will not be available. The team will also participate in 1x1s during the conference. To inquire on potential collaborations and meetings, please contact the team via the TLC (tlcbio.com) company website.
The invite-only JP Morgan Healthcare Conference has been and still is one of the largest and most influential healthcare industry events held annually for over 40 years, bringing together executives, investors, bankers, analysts, and policymakers across the biopharma, med-tech, healthcare services, and digital health sectors.
